← Back to Vaccine Database

gB/MF59

Protein based vaccine · VDDBV0284

Target & Classification

CMVCytomegalovirus
Protein based vaccine
Cytomegalovirus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT00133497 Phase 2Cytomegalovirus Infections